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Purpose: With the improved surgical techniques and immunosuppression available to-
day, conventional prognostic factors have taken on less significance. Accordingly, the 
native renal function of the donor is thought to be more important. Thus, we analyzed 
the prognostic significance of the donor’s renal function as assessed by 24-hour urine 
creatinine clearance on kidney graft survival for 10 years after living kidney trans-
plantation.
Materials and Methods: From January 1998 to July 2000, 71 living kidney trans-
plantations were performed at a single institution. From among these, 68 recipients 
were followed for more than 6 months and were included in the present analysis. We 
analyzed kidney graft survival according to clinical parameters of the donor and the 
recipient. 
Results: Mean follow-up duration of recipients after living kidney transplantation was 
115.0±39.4 months (range, 10 to 157 months), and 31 recipients (45.6%) experienced 
kidney graft loss during this time period. Estimated mean kidney graft survival time 
was 131.8±6.2 months, and 5-year and 10-year kidney graft survival rates were esti-
mated as 88.2% and 61.0%, respectively. Donor’s mean 24-hour urine creatinine clear-
ance (Ccr) before kidney transplantation was 122.8±21.2 ml/min/1.73 m
2 (range, 70.1 
to 186.6 ml/min/1.73 m
2). The 10-year kidney graft survival rates for cases stratified 
by a donor’s Ccr lower and higher than 120 ml/min/1.73 m
2 were 39.0% and 67.2%, re-
spectively (p=0.005). In univariate and multivariate analysis, donor’s Ccr was retained 
as an independent prognostic factor of kidney graft survival (p=0.001 and 0.005, re-
spectively). 
Conclusions: Donor’s 24-hour urine Ccr before living kidney transplantation was an 
independent prognostic factor of kidney graft survival. Therefore, it should be consid-
ered before living kidney transplantation.  
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INTRODUCTION
Kidney transplantation (KT) is one of the treatments wide-
ly used for patients with end-stage renal disease. KT is con-
sidered the best therapeutic method in patients with 
end-stage renal disease because of the increased life ex-
pectancy of the recipients [1].
The factors known to influence the survival of the trans-
planted kidney in living KT patients are as follows: the do-
nor’s age, the level of human leukocyte antigen (HLA) his-
tocompatibility, acute rejection, and the type of im-
munosuppressive drugs used [2-8]. However, with the im-
proved surgical techniques and effective immunosuppre-
ssion available today, conventional prognostic factors have 
taken on less significance [2]. Accordingly, the native renal 
function of the donor is thought to be more important.Korean J Urol 2012;53:126-130
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The most objective and universal index of renal function 
is the glomerular filtration rate (GFR), which measures the 
amount of blood plasma filtered from the glomerulus in the 
unit of time (ml/min). The GFR is measured by the crea-
tinine clearance (Ccr) from the urine collected for 24 hours. 
To the best of our knowledge, no study to date has inves-
tigated the relationship between the donor’s 24-hour urine 
Ccr before KT and the recipient’s kidney graft survival 
(KGS) after surgery. 
Therefore, on the basis of 10-year follow-up results after 
surgery, we tried to determine how the 24-hour urine Ccr 
of the donor, measured before living KT, can influence the 
KGS of the recipient after surgery. 
MATERIALS AND METHODS
This study was approved by the Institutional Review Board 
of Hallym University, Chuncheon Sacred Heart Hospital. 
A total of 71 patients who underwent living KT performed 
by single surgeon were recruited from a single institution 
from January 1998 to July 2000. Sixty-eight of the 71 recipi-
ents were retrospectively included in this study according 
to the following criteria: the donor’s 24-hour urine Ccr was 
measured before KT, the patient was followed for more 
than 6 months, KGS was verified, and the patient did not 
undergo re-operation. Clinical data were retrospectively 
reviewed. The following parameters were recorded in each 
case: the donor’s age and gender, the recipient’s age and 
gender, blood relationship, the donor’s 24-hour urine Ccr 
before KT, the recipient’s 24-hour urine Ccr and KGS at fol-
low-up, acute rejection, HLA and HLA-DR matching, and 
drugs used for immune suppression.
The recipients with kidney graft loss or who were fol-
lowed up for less than 6 months after KT were excluded 
from our study because their KGS was associated with in-
creased perioperative morbidity or mortality. Renal func-
tion was assessed by GFR by use of 24-hour urine Ccr ac-
cording to the formula:
24-hour urine Ccr=urine creatininexurine volume/pla-
sma creatinine. 
All values for 24-hour urine Ccr were measured during 
hospitalization and were corrected on the basis of the body 
surface area to millimeter per minute per 1.73 m
2 for exact 
and objective outcomes. Acute rejection was confirmed 
through kidney biopsy in patients with clinical abnormal-
ities, such as decreased urine output or serum creatine lev-
el increased by 25% or higher. Kidney graft loss was defined 
as either ‘dialysis in need’ or ‘death associated with renal 
failure’ but not as ‘death with a functioning graft.’ Triple 
therapy was applied for immunosuppressive therapy, and 
cyclosporine was used as the main immunosuppressive 
drug. Corticosteroid therapy was used in all recipients, and 
azathioprine and mycophenolate mofetil were used in 30 
and 38 recipients, respectively.
SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA) was used 
for all statistical analyses. The cutoff value for donor’s 
24-hour urine Ccr was calculated by the minimum p-value 
approach and corrected by the Bonferroni correction 
method. The Kaplan-Meier method was used to analyze 
KGS, and the log-rank test was used to compare the inves-
tigated groups. The prognostic values of parameters were 
evaluated by using both univariate and multivariate Cox 
proportional hazards models. All p-values were two-sided, 
and p＜0.05 was considered to be statistically significant.
RESULTS
The recipients’ mean age was 36.8 years (range, 20 to 59 
years), and there were 37 males (54.4%). The most common 
primary cause of end-stage renal disease was glomer-
ulonephritis (13 recipients, 19.1%). After KT, the mean du-
ration of the follow-up period was 115.0±39.4 months 
(range, 10 to 157 months). The mean 24-hour urine Ccr lev-
els of the surviving recipients, measured at 1, 5, and 10 
years after KT, were 69.8±16.0 (67 recipients), 63.5±22.6 
(60 recipients), and 59.9±34.2 ml/min/1.73 m
2 (38 recipi-
ents), respectively.
The donors’ mean age was 35.9 years (range, 21 to 58 
years), and there were 42 males (61.8%). Thirty donors 
(44.1%) were related to the recipients. The mean 24-hour 
urine Ccr level of the donors measured before KT was 
122.8±21.2 ml/min/1.73 m
2. There were 21 cases of acute 
rejection (30.9%) (Table 1). 
During the follow-up period, there were 31 cases (45.6%) 
of graft loss after KT. The mean KGS time of the recipients 
was 131.8±6.2 months, and the estimated 5-year and 
10-year KGS rates were 88.2% and 61.0%, respectively. 
The optimal cutoff value for donor’s 24-hour urine Ccr 
was 120.05 ml/min/1.73 m
2 (p＜0.001, sensitivity 86.5%, 
specificity 35.5%). Therefore, 120 ml/min/1.73 m
2 was de-
termined as the cutoff value. When the donor’s 24-hour 
urine Ccr before KT was divided into less than 120 
ml/min/1.73 m
2 (n=16) and greater than 120 ml/min/1.73 
m
2 (n=52), the mean KGS time of each group was 96.0±9.6 
months and 139.5±6.8 months, respectively (p=0.005). The 
estimated 10-year KGS rate of each group was 39.0% and 
67.2%, respectively (Fig. 1).
The results of the univariate analysis showed that the 
24-hour urine Ccr of the donor before KT was a significant 
risk factor of kidney graft loss (p=0.001, hazard ratio [HR], 
0.163). In the multivariate analysis, the 24-hour urine Ccr 
of the donor before KT remained an independent risk factor 
of kidney graft loss when corrected for all other variables 
(p=0.005, HR, 0.143) (Table 2).
DISCUSSION
KT is the best therapeutic method for patients with end-stage 
renal disease and has shown significant long-term out-
comes. In about 800 cases of living KT investigated be-
tween 1991 and 2001, Foster et al. [9] reported that the 
5-year KGS rate ranged from 82.9 to 89.1%. Using the 
United Network for Organ Sharing registry, between 1998 
to 2001, Cecka [10] analyzed 14,162 cases of living KT and Korean J Urol 2012;53:126-130
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TABLE 1. Characteristics of the donors and recipients
Characteristic Overall (n=68)  Group A (n=16) Group B (n=52) p-value
Age (yr), mean (SD)
    Donor
    Recipient
Male sex, n(%)
    Donor
    Recipient
Primary cause of ESRD, n(%)
    Glomerulonephritis
    Diabetes
    Hypertension
    Others
Donor's Ccr before KT, mean (SD)
a 
Recipient's Ccr at 10 years after KT, mean (SD)
a
Relation, n(%)
    Related 
    Offsprings
    Parents
    Siblings
    Unrelated 
Acute rejection, n(%)
HLA matching, n(%)
    1-3
    4-6
HLA-DR matching, n(%)
    0-1
    2
Immunosuppression, n(%)
    CS, PD, AZT
    CS, PD, MMF
35.9 (9.4)
36.8 (9.2)
   42 (61.8)
   37 (54.4)
   13 (19.1)
   10 (14.7)
     7 (10.3)
   38 (55.9)
122.8 (21.2)
59.9 (34.2)
   30 (44.1) 
     3 (4.4) 
     4 (5.9) 
   23 (33.8) 
   38 (55.9) 
   21 (30.9)
   63 (92.6) 
     5 (7.4)
   62 (91.2)
     6 (8.8)
   30 (44.1)
   38 (55.9)
37.8 (8.6)
34.9 (10.3)
     7 (43.8)
     9 (56.3)
     3 (18.8)
     1 (6.3)
     2 (12.5) 
   10 (62.5)
95.7 (17.1)
28.3 (37.7)
     9 (56.3)
     1 (6.3)
     2 (12.5)
     6 (37.5)
     7 (43.7)
     8 (50.0)
   16 (100)
     0 (0)
   15 (93.8)
     1 (6.2)
     7 (43.7)
     9 (56.3)
35.3 (9.6)
37.3 (8.8)
   35 (67.3)
   28 (53.8)
   10 (19.2)
     9 (17.3)
     5 (9.6)
   28 (53.8)
131.1 (14.2)
69.7 (26.6)
   21 (40.4)
     2 (3.8)
     2 (3.8)
   17 (32.8)
   31 (59.6)
   13 (25.0)
   47 (90.4)
     5 (9.6)
   47 (90.4)
     5 (9.6)
   23 (44.2)
   29 (55.8)
0.356
0.369
0.090
0.866
b
＜0.001
＜0.001
0.352
0.058
0.198
0.678
0.801
Group A: Donor's Ccr before KT ≤120 ml/min/1.73 m
2, Group B: Donor's Ccr before KT ＞120 ml/min/1.73 m
2.
ESRD, end stage renal disease; Ccr, 24-hour urine creatinine clearance; KT, kidney transplantation; HLA, human leukocyte antigen; 
n, cases; SD, standard deviation; CS, cyclosporin; PD, prednisolone; AZT, azathioprine; MMF, mycophenolate mofetil. 
a: Ccr unit: ml/min/1.73 m
2, 
b: no statistical analysis.
FIG. 1. Kaplan-Meier curve for kidney graft survival of reci-
pients according to donor's Ccr before kidney transplantation. 
Ccr, 24-hour urine creatinine clearance.
reported that the 10-year KGS rate was 68%. In our study, 
between 1998 and 2000, the recipient’s 5- and 10-year KGS 
rates of 88.2% and 61.0%, respectively, were similar to 
those reported in the previous studies. 
Many studies have reported that the donor’s age, acute 
rejection, the level of HLA antigen histocompatibility, and 
the type of immunosuppressive drugs are risk factors that 
influence the KGS rate [2-8]. However, with improved sur-
gical technologies and the prevention of postoperative com-
plications and the development of new immunosuppre-
ssive drugs, the KGS rate has increased from the late 
1980s, and the conventional prognostic factors have taken 
on less significance [2]. Therefore, the native renal function 
of the donor is thought to be more important for the KGS 
rate after surgery. 
Among the various indices of renal function, the most ob-
jective and universal index is the GFR, which is measured 
by the 24-hour urine Ccr. The donor’s renal function, as 
measured by the serum creatinine, not Ccr, was assessed 
in previous studies [11]. To the best of our knowledge, this 
is the first study investigating the influence of the donor’s 
24-hour urine Ccr, measured before living KT, on the KGS 
rate after surgery.Korean J Urol 2012;53:126-130
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TABLE 2. Univariate and multivariate analyses predicting probability of kidney graft survival
Variables
Univariate analysis Multivariate analysis
HR 95% CI p-value HR 95% CI p-value
Recipient's gender 
    Female sex
Recipient's age
Donor's gender 
    Female sex
Donor's age
Relation
    Sibling vs. parent/offspring
    Unrelated vs. parent/offspring
HLA matching 
    4-6 vs. 1-3
HLA-DR matching 
    2 vs. 0-1
Acute rejection
Immunosuppression 
    CS, PD, MMF vs. CS, PD, AZT
Donor's Ccr 
    ≥120
1.013
0.954
0.706
1.030
1.513
1.170
0.043
0.734
3.359
0.952
0.163
0.340-3.016
0.894-1.018
0.217-2.292
0.977-1.086
  0.177-12.956
0.144-9.511
    0.001-219.067
0.095-5.647
  1.125-10.025
0.082-8.216
0.053-0.495
0.982
0.158
0.562
0.276
0.879
0.705
0.883
0.471
0.766
0.030
0.871
0.001
1.104
0.950
0.232
1.025
4.521
1.555
0.000
3.186
4.790
0.998
0.143
0.270-4.516
0.882-1.022
0.050-1.073
0.948-1.109
  0.270-75.597
  0.134-18.118
0.000
  0.253-40.082
  1.265-18.134
  0.035-15.341
0.037-0.557
0.891
0.170
0.062
0.530
0.402
0.294
0.724
0.988
0.370
0.021
0.890
0.005
HR, hazard ratio; CI, confidence interval; HLA, human leukocyte antigen; CS, cyclosporin; PD, prednisolone; MMF, mycophenolate 
mofetil; AZT, azathioprine; Ccr, 24-hour urine creatinine clearance.
Lee et al. [12] reported that the mean recipient’s 24-hour 
urine Ccr level showed a 141.5% increase at 1 week after 
KT, although they did not assess the long-term renal func-
tion change. They stated that the residual function of the 
recipient’s native kidney function measured before KT did 
not show much correlation with the recipient’s renal func-
tion after KT. This means that the transplanted kidney 
function decides most of the recipient’s renal function after 
KT. Therefore, we thought that one of the most important 
factors affecting KGS was the donor’s renal function meas-
ured before KT, as assessed by the 24-hour urine Ccr.
 We considered the donor’s 24-hour urine Ccr value of 120 
ml/min/1.73 m
2 as a division point. This was calculated by 
the minimum p-value approach compensated by the 
Bonferroni correction method (p＜0.001). When the do-
nor’s 24-hour urine Ccr level before living KT was divided 
into less than 120 ml/min/1.73 m
2 and above this cutoff, the 
10-year KGS rates for each group were 39.0% and 67.2%, 
respectively (p=0.005). The donor’s 24-hour urine Ccr level 
before living KT was a significant prognostic factor in the 
univariate analysis (p=0.001; HR, 0.163) and also in the 
multivariate analysis, which was corrected for all other 
variables (p=0.005; HR, 0.143) (Table 2). Therefore, the do-
nor’s 24-hour urine Ccr must be measured before living KT 
and considered as a prognostic factor of KGS. 
There are conflicting opinions about the influence of the 
donor’s age on KGS. Kaplan et al. [2] reported that the do-
nor’s age was a significant risk factor, i.e., when the donor 
was older than 18 years, the kidney graft loss rate was 
increased. However, this result is in all likelihood due to 
a lesser functional reserve of the kidney, along with age-re-
lated injury, decreasing the kidney’s ability to withstand 
further damage. Park et al. [8] reported that the donor’s age 
was not related to KGS in 57 months of follow-up after KT. 
Our study also showed no correlation between the donor’s 
age and KGS.
Blood relationship between donor and recipient was con-
sidered to be an important risk factor in the past [13], but 
not in recent studies. Park et al. [8] reported that blood rela-
tionship was not a significant risk factor, and Kaplan et al. 
[2] stated that the advantage of living donor kidneys held 
equally true for unrelated donors. Blood relationship was 
not considered as a significant risk factor in our study, and 
we consider that transplanted kidneys with good renal 
function are more important than blood relationship.
With the improved immunosuppression available today, 
HLA matching has taken on less significance, although 
this is still considered to be an important prognostic factor 
[2,14]. It was not considered as a significant risk factor in 
our study. However, it is difficult to determine its sig-
nificance with statistic values only, because our result did 
not have a high confidence level. This is one of the weak 
points of our study.
Many studies have considered acute rejection as an im-
portant risk factor for KGS [2,15]. In our study, the number 
of recipients with acute rejection differed between the two 
groups, although there was no statistical difference. It was 
thought that the difference in HLA matching was one rea-
son for this difference. In the multivariate analysis, it was 
also an important risk factor, and the kidney graft loss rate 
was 4.79 times higher when there was acute rejection. 
Therefore, acute rejection is considered to be an important 
risk factor that determines KGS, together with the donor’s 
24-hour urine Ccr measured before KT.Korean J Urol 2012;53:126-130
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A few studies showed that different immunosuppressive 
drugs make a difference in the long-term outcome [2,14, 
15]. Both the short-term outcome and the acute rejection 
rate were improved, but the long-term outcome did not im-
prove much. In our study, type of immunosuppressive drug 
was also not considered as a risk factor.
There are a few limitations in our study. First, our study 
followed a retrospective design. Therefore, several varia-
bles, such as newly developed immunosuppressive drugs 
or interleukin-2 antibody, which may better reflect clinical 
outcomes, were not included in the analyses [16,17]. 
Second, although our study continuously followed up on 
the recipients after KT, the 24-hour urine Ccr was not 
measured on a regular basis for all recipients. However, our 
study included most of the conventional variables asso-
ciated with KGS, and we studied recipients for 10 long 
years. Third, other indices of renal function, such as the 
24-hour albuminuria or more currently accepted iothala-
mic clearance test, need to be assessed. Last, the number 
of cases in our study was relatively smaller than in previous 
studies, although we followed the patients for 10 years.
Despite these limitations, our study is significant as the 
first report on the influence of the donor’s 24-hour urine Ccr 
measured before living KT, which is the most objective and 
universal index of renal function, on KGS. In the future, 
as surgical technology and immunosuppressive drugs are 
developed and the rates of KGS rise, the influence of the 
donor’s renal function on KGS will increase.
CONCLUSIONS
The renal function of the donor measured before living KT, 
using the 24-hour urine Ccr, was a significant prognostic 
factor influencing KGS. The objective renal function of the 
donor needs to be evaluated for living KT, and it should be 
considered before living KT.
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